Peter Baum
- Immunology top 2%
- Immunotherapy and Immune Responses 10
- T-cell and B-cell Immunology 7
- Immune Cell Function and Interaction 5
- Cell Biology top 1%
- Microtubule and mitosis dynamics 5
- Molecular Biology top 5%
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 5
- Virus-based gene therapy research 4
- Immunology and Allergy top 5%
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- CAR-T cell therapy research 4
- Co-authors
- Carl W. AndersonR F GestelandBreck ByersLoretta GoetschClement E. FurlongMark WineyJames B. LewisJohn F. Atkins
- Journals
- Journal of Clinical Oncology (5 papers)Blood (5 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Peter Baum
38 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Immunology 1.4k
- Cell Biology 815
- Molecular Biology 2.1k
- Genetics 766
- Immunology and Allergy 144
Countries citing papers authored by Peter Baum
This map shows the geographic impact of Peter Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Baum more than expected).
Fields of papers citing papers by Peter Baum
This network shows the impact of papers produced by Peter Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Baum. The network helps show where Peter Baum may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 2 | |
| 2 | 2011 | 6 | |
| 3 | 2009 | 18 | |
| 4 | 2007 | 1 | |
| 5 | 2005 | 146 | |
| 6 | 2002 | 77 | |
| 7 | 2000 | 20 | |
| 8 | 1999 | 254 | |
| 9 | 1998 | 171 | |
| 10 | LERK-2, a binding protein for the receptor-tyrosine kinase ELK, is evolutionarily conserved and expressed in a developmentally regulated pattern. | 1994 | 23 |
| 11 | 1994 | 126 | |
| 12 | 1994 | 12 | |
| 13 | 1994 | 290 | |
| 14 | 1992 | 98 | |
| 15 | 1991 | 12 | |
| 16 | 1988 | 43 | |
| 17 | 1988 | 122 | |
| 18 | 1976 | 208 | |
| 19 | Processing of Adenovirus 2-Induced Proteinsbreakdown → | 1973 | 710 |
| 20 | [TOXIC HEMOLYTIC ANEMIAS]. | 1963 | 9 |
About Peter Baum
Peter Baum is a scholar working on Immunology, Genetics and Immunology and Allergy, having authored 38 papers that have together received 3.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Microtubule and mitosis dynamics (5 papers), Immune Cell Function and Interaction (5 papers), Virus-based gene therapy research (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Immunology (1.4k citations), Cell Biology (815 citations) and Molecular Biology (2.1k citations). Peter Baum has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Carl W. Anderson, R F Gesteland, Breck Byers, Loretta Goetsch, Clement E. Furlong, Mark Winey, James B. Lewis, John F. Atkins, Yuetsu Tanaka and Patrice Hermann. Their work appears in journals such as Journal of Clinical Oncology, Blood, Proceedings of the National Academy of Sciences, Cancer Research and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.